Skip to main content
OpenTrials
Completed

NCT Number: NCT00280358

A Study in Healthy Volunteers to Evaluate Serum and Urine Levels of the Investigational Product Versus Comparator.

The purpose of the study is to obtain initial pharmacokinetic data in healthy patients after dosing a combination of the study medications.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Research Site

Lenexa, Kansas, 66219, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Non-smokers, BMI 18-29, no current medications

Exclusion criteria

  • Significant conditions or disease

Treatment and study plan

Fluticasone propionate

Drug

formoterol fumarate

Drug

Primary outcomes

  1. Levels of study medication in blood and urine.

Secondary outcomes

  1. Safety/tolerability

Sponsors and collaborators

Lead sponsor

Dey

Industry

Registry information

Important dates

Study completion
2005
First posted
Jan 23, 2006
Registry last updated
Mar 7, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.